About Sayeed Ikramuddin, MD
Specialties & classifications: Bariatric Surgery · General Surgery · Surgery
Sayeed Ikramuddin is a bariatric surgeon in Minneapolis, MN. Contact the practice to discuss surgical options, appointment availability and insurance coverage.
Does Sayeed Ikramuddin provide bariatric surgery?
The linked professional profile lists bariatric surgical care. Contact the practice to confirm available procedures and appointment availability. Source
Education and Training
- Fellowship · 1997
The Ohio State University College of Medicine, Surgery (General Surgery), 1997
Source ↗ - Residency · 1996
SUNY Upstate University Hospital, Surgery (General Surgery), 1996
Source ↗ - Medical school · 1990
Albany Medical College, MD, 1990
Source ↗
Source-reported information; confirm current details directly.
Reported credentials
Source-reported information; confirm current details directly.
Reported affiliations
- FAIRVIEW EXPRESS CARE Source ↗
- UNIVERSITY OF MINNESOTA HEALTH CLINICS AND SURGERY CENTER INC Source ↗
Source-reported information; confirm current details directly.
Selected publications
- Robotic Use, Operative Length, and Readmission after Duodenal Switch: A Retrospective Ten-Year MBSAQIP Analysis Using an Interaction Model. · 2026 Source ↗
- Defining the impact of time to surgery on survival after colon cancer diagnosis: A national trend analysis. · 2026 Source ↗
- Traditional Risk Factors Are Not Associated with the Rise of Early-Onset Colorectal Cancer: An All of Us Study. · 2026 Source ↗
- 1-year outcomes of semaglutide, tirzepatide, and sleeve gastrectomy in obesity in type 2 diabetes: a retrospective cohort study. · 2026 Source ↗
- Target Trial Emulation of 6-Month Weight Change after Endoscopic Sleeve Gastroplasty and Sleeve Gastrectomy: A Retrospective Cohort Study. · 2026 Source ↗
- Sepsis After Elective Aortic Root Replacement: An Analysis Using the National Inpatient Sample. · 2026 Source ↗
- Ninety-Day Readmission and Morbidity Following Liver Transplantation for MASLD. · 2026 Source ↗
- Association of chronic disease risk and physical activity measured by wearable devices in the All of Us program. · 2026 Source ↗
- National trends in ambulatory and inpatient minimally invasive adrenalectomy in the United States. · 2026 Source ↗
- A history of bariatric surgery is associated with a shorter length of stay for patients undergoing renal transplant. · 2026 Source ↗
- A Case Series Analysis of Hospital Volume in a New Era of US Bariatric Surgery within the Nationwide Readmissions Database. · 2025 Source ↗
- Kidney transplantation after bariatric surgery-Outcomes from a 30-year experience. · 2026 Source ↗
- Cardiometabolic Health and Bariatric Surgery: A 25-Year Longitudinal Cohort Study in CARDIA Participants. · 2025 Source ↗
- Outcomes of concomitant laparoscopic sleeve gastrectomy and cholecystectomy. · 2025 Source ↗
- Primary Aldosteronism Surgery Outcomes Under Current Blood Pressure Guidelines. · 2026 Source ↗
- Artifacts in spatial transcriptomics data: their detection, importance, prevalence, and prevention. · 2025 Source ↗
- Inhibition of fatty acid binding protein suppresses pancreatic cancer progression and metastasis. · 2025 Source ↗
- Predicting Weight Loss After Vertical Sleeve Gastrectomy Using a Whole-genome Sequencing-derived Polygenic Risk Score in the All of Us Cohort. · 2025 Source ↗
- Venous Thromboembolism After Bariatric Surgery: An Analysis of Predictors and Trends in Two Large Datasets. · 2025 Source ↗
- Morbidity of emergent versus elective hiatal hernia repair: an analysis of the NIS database. · 2025 Source ↗
- Ketogenesis mitigates metabolic dysfunction-associated steatotic liver disease through mechanisms that extend beyond fat oxidation. · 2025 Source ↗
- Single-cell RNA sequencing reveals a reprogramming of hepatic immune cells and a protective role for B cells in MASH-driven HCC. · 2025 Source ↗
- Predictors and Trends of Hemorrhage After Bariatric Surgery Using Two Large National Datasets: A Retrospective Observational Study. · 2025 Source ↗
- Bariatric Surgery Is Associated With Reduced Incidence of Mild Cognitive Impairment and Alzheimer Disease and Related Dementias: A Retrospective Cohort Study. · 2025 Source ↗
- Bariatric surgery prior to pancreas transplantation: a retrospective matched case-control study. · 2025 Source ↗
- TREM2 macrophages mediate the beneficial effects of bariatric surgery against MASH. · 2025 Source ↗
- Best Practice Alert to Promote Screening for Primary Aldosteronism Among People With Apparent Treatment-Resistant Hypertension. · 2024 Source ↗
- Rates and Risk Factors for 30-Day Morbidity After One-Stage Vertical Banded Gastroplasty Conversions: A Retrospective Analysis. · 2024 Source ↗
- Prediction of 30-Day Morbidity and Mortality After Conversion of Sleeve Gastrectomy to Roux-en-Y Gastric Bypass: Use of an Artificial Neural Network. · 2024 Source ↗
- Effect of beta-blocker therapy on weight loss outcomes after sleeve gastrectomy & Roux-en-Y gastric bypass. · 2023 Source ↗
- Desmoglein 2 Functions as a Receptor for Fatty Acid Binding Protein 4 in Breast Cancer Epithelial Cells. · 2023 Source ↗
- Pre-Operative Substance Use Disorder is Associated with Higher Risk of Long-Term Mortality Following Bariatric Surgery. · 2023 Source ↗
- Fecal Microbiota Transplantation for Fulminant Clostridioides Difficile Infection: A Combined Medical and Surgical Case Series. · 2023 Source ↗
- Association of Pre-operative Arthritis with Long-Term Mortality Following Bariatric Surgery. · 2023 Source ↗
- Endoscopic polypectomy for malignant polyps: Should tumor location (right versus left side) guide clinical decisions? · 2023 Source ↗
- Prediction of thirty-day morbidity and mortality after duodenal switch using an artificial neural network. · 2023 Source ↗
- Obesity and Pancreatic Cancer: Recent Progress in Epidemiology, Mechanisms and Bariatric Surgery. · 2022 Source ↗
- Fatty acid binding protein 4 regulates pancreatic cancer cell proliferation via activation of nuclear factor E2-related factor 2. · 2022 Source ↗
- ASMBS Position Statement on the Impact of Metabolic and Bariatric Surgery on Nonalcoholic Steatohepatitis. · 2022 Source ↗
- Gastroesophageal Reflux Disease Outcomes After Vertical Sleeve Gastrectomy and Gastric Bypass. · 2021 Source ↗
- Metabolic surgery may protect against admission for COVID-19 in persons with nonalcoholic fatty liver disease. · 2021 Source ↗
- The Role of Preoperative Anemia in Predicting Short-Term Morbidity and Mortality After Roux-en-Y Gastric Bypass. · 2021 Source ↗
- Bariatric surgery outcomes in Medicare beneficiaries. · 2021 Source ↗
- Peri-operative antibiotics acutely and significantly impact intestinal microbiota following bariatric surgery. · 2020 Source ↗
- Weight Loss Thresholds for Mortality Reduction Post Bariatric Surgery. · 2020 Source ↗
- Nonalcoholic Steatohepatitis-Reply. · 2020 Source ↗
- Bariatric Surgery is Associated With Decreased Progression of Nonalcoholic Fatty Liver Disease to Cirrhosis: A Retrospective Cohort Analysis. · 2020 Source ↗
- Merit of an Ursodeoxycholic Acid Clinical Trial in COVID-19 Patients. · 2020 Source ↗
- Nonalcoholic Steatohepatitis: A Review. · 2020 Source ↗
- The Impact of Bariatric Surgery on Breast Cancer Recurrence: Case Series and Review of Literature. · 2020 Source ↗
- Prediction of thirty-day morbidity and mortality after laparoscopic sleeve gastrectomy: data from an artificial neural network. · 2020 Source ↗
- Influence of Asian Ethnicities on Short- and Mid-term Outcomes Following Laparoscopic Sleeve Gastrectomy. · 2019 Source ↗
- Antibiotic-induced Disruption of Intestinal Microbiota Contributes to Failure of Vertical Sleeve Gastrectomy. · 2019 Source ↗
- Comment on: Altered gut microbiome after bariatric surgery and its association with metabolic benefits: a systematic review. · 2019 Source ↗
- Analysis of vitamin levels and deficiencies in bariatric surgery patients: a single-institutional analysis. · 2019 Source ↗
- Racial disparities in perioperative outcomes after bariatric surgery. · 2019 Source ↗
- Serum FABP4 concentrations decrease after Roux-en-Y gastric bypass but not after intensive medical management. · 2019 Source ↗
- Preventing Macrovascular Events With Bariatric Surgery. · 2018 Source ↗
- Surgical repair of perforated peptic ulcers: laparoscopic versus open approach. · 2019 Source ↗
- EUS-Guided Endoscopic Gastrointestinal Anastomosis with Lumen-Apposing Metal Stent: Feasibility, Safety, and Efficacy. · 2018 Source ↗
- Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study. · 2018 Source ↗
- Bariatric Surgery: A Perspective for Primary Care. · 2017 Source ↗
- National Trends in Bariatric Surgery 2012-2015: Demographics, Procedure Selection, Readmissions, and Cost. · 2017 Source ↗
- Outcomes of Endoscopic Retrograde Cholangiopancreatography (ERCP) and Sphincterotomy for Suspected Sphincter of Oddi Dysfunction (SOD) Post Roux-En-Y Gastric Bypass. · 2017 Source ↗
- National Differences in Remission of Type 2 Diabetes Mellitus After Roux-en-Y Gastric Bypass Surgery-Subgroup Analysis of 2-Year Results of the Diabetes Surgery Study Comparing Taiwanese with Americans with Mild Obesity (BMI 30-35 kg/m<sup>2</sup>). · 2017 Source ↗
- Randomized sham-controlled trial evaluating efficacy and safety of endoscopic gastric plication for primary obesity: The ESSENTIAL trial. · 2017 Source ↗
- Sleeve gastrectomy drives persistent shifts in the gut microbiome. · 2017 Source ↗
- Two-Year Outcomes of Vagal Nerve Blocking (vBloc) for the Treatment of Obesity in the ReCharge Trial. · 2017 Source ↗
- Endoscopic Management of Vertical Banded Gastroplasty Stricture: Feasibility, Safety, and Efficacy. · 2016 Source ↗
- Trends in Bariatric Surgery: Procedure Selection, Revisional Surgeries, and Readmissions. · 2016 Source ↗
- Videoconferencing for multidisciplinary evaluation in single-session cholecystectomy and ERCP. · 2016 Source ↗
- Durability of Addition of Roux-en-Y Gastric Bypass to Lifestyle Intervention and Medical Management in Achieving Primary Treatment Goals for Uncontrolled Type 2 Diabetes in Mild to Moderate Obesity: A Randomized Control Trial. · 2016 Source ↗
- Clinical Outcomes of Metabolic Surgery: Efficacy of Glycemic Control, Weight Loss, and Remission of Diabetes. · 2016 Source ↗
- FGF 19 and Bile Acids Increase Following Roux-en-Y Gastric Bypass but Not After Medical Management in Patients with Type 2 Diabetes. · 2016 Source ↗
- Transhepatic tract for visualization of the remnant stomach after Roux-en-Y gastric bypass. · 2016 Source ↗
- The future of the Roux-en-Y gastric bypass. · 2016 Source ↗
- Novel endoscopic management of a pancreatico-biliary limb obstruction by the creation of an entero-enterostomy following Roux-en-Y gastric bypass. · 2016 Source ↗
- Endoscopic-guided transgastric stapled stricturoplasty. · 2016 Source ↗
- Roux-en-Y Gastric Bypass Acutely Decreases Protein Carbonylation and Increases Expression of Mitochondrial Biogenesis Genes in Subcutaneous Adipose Tissue. · 2015 Source ↗
- Bariatric surgery and bone health. · 2015 Source ↗
- Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial. · 2015 Source ↗
- Sustained Weight Loss with Vagal Nerve Blockade but Not with Sham: 18-Month Results of the ReCharge Trial. · 2015 Source ↗
- Preserved Insulin Secretory Capacity and Weight Loss Are the Predominant Predictors of Glycemic Control in Patients With Type 2 Diabetes Randomized to Roux-en-Y Gastric Bypass. · 2015 Source ↗
- EUS-guided sutured gastropexy for transgastric ERCP (ESTER) in patients with Roux-en-Y gastric bypass: a novel, single-session, minimally invasive approach. · 2015 Source ↗
- The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. · 2015 Source ↗
- Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial. · 2014 Source ↗
- The effect of vagal nerve blockade using electrical impulses on glucose metabolism in nondiabetic subjects. · 2014 Source ↗
- Endoscopic sutured gastropexy: a novel technique for performing a secure gastrostomy (with videos). · 2014 Source ↗
- Effects on GLP-1, PYY, and leptin by direct stimulation of terminal ileum and cecum in humans: implications for ileal transposition. · 2014 Source ↗
- New insights on bariatric surgery outcomes. · 2013 Source ↗
- Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. · 2013 Source ↗
- Optimizing outcomes in bariatric surgery: a primer in patient selection. · 2012 Source ↗
- Cost-effectiveness of Roux-en-Y gastric bypass in type 2 diabetes patients. · 2009 Source ↗
- Surgical management of gastroesophageal reflux disease in obesity. · 2008 Source ↗
- Open and laparoscopic Roux-en-Y gastric bypass: our techniques. · 2007 Source ↗
Source-reported information; confirm current details directly.
Professional identifier
NPI: 1417988510
Ratings & reviews
★ 3.5/ 5
22 combined ratingsWebMD
Source ratings reflect the dates shown. Combined totals may include overlapping reviewers.
Write a review